Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders??? Deficit (Unaudited)

v3.23.1
Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2021 $ 282,217 $ 53,064,616 $ (57,515,129) $ 189,255 $ (3,979,041)
Balance (in Shares) at Dec. 31, 2021 282,216,632        
Common stock issued for accounts payable $ 90 2,084 2,174
Common stock issued for accounts payable (in Shares) 90,859        
Common stock issued for compensation $ 500 13,750 14,250
Common stock issued for compensation (in Shares) 500,000        
Common stock issued for conversion of Series C preferred stock $ 1,543 10,457 12,000
Common stock issued for conversion of Series C preferred stock (in Shares) 1,543,151        
Common stock issued in connection with debt $ 824 12,139     12,963
Common stock issued in connection with debt (in Shares) 823,529        
Preferred stock dividends (14,005) (14,005)
Accretion of stock-based compensation 42,702 42,702
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 957,556 957,556
Net loss (1,906,399) (13,020) (1,919,419)
Balance at Mar. 31, 2022 $ 285,174 54,103,304 (59,435,533) 176,235 (4,870,820)
Balance (in Shares) at Mar. 31, 2022 285,174,171        
Balance at Dec. 31, 2022 $ 350,270 55,141,503 (62,693,184) 150,742 (7,050,669)
Balance (in Shares) at Dec. 31, 2022 350,270,172        
Common stock issued for cash and accrued compensation $ 54,545 245,455 300,000
Common stock issued for cash and accrued compensation (in Shares) 54,545,455        
Common stock issued for professional fees $ 6,667 33,333 40,000
Common stock issued for professional fees (in Shares) 6,666,667        
Common stock issued for compensation $ 9,636 43,364 53,000
Common stock issued for compensation (in Shares) 9,636,364        
Common stock issued for conversion of Series C preferred stock $ 26,586 74,814 101,400
Common stock issued for conversion of Series C preferred stock (in Shares) 26,585,614        
Preferred stock dividends (13,687) (13,687)
Accretion of stock-based compensation 12,137 12,137
Net loss (706,365) (16,722) (723,087)
Balance at Mar. 31, 2023 $ 447,704 $ 55,550,606 $ (63,413,236) $ 134,020 $ (7,280,906)
Balance (in Shares) at Mar. 31, 2023 447,704,272